Thank you for registering Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in
The evidence spans liver protection, kidney protection, and systemic anti-fibrotic activity
Oct 6 : Arcutis Biotherapeutics is adding another indication for its psoriasis cream, Zoryve, after the FDA approved the companys supplemental New Drug Application (sNDA) to expand the treatment for children ages 6 to 11
Switching between GLP-1 receptor agonists is possible and does occur clinically, but it requires physician guidance
According to NICE guidance (NG12), visible blood in urine requires urgent referral (within 2 weeks) for people aged 45 and over to exclude urological cancer
Increased Cellular Protection: The combination works to reduce oxidative stress by neutralizing free radicals more effectively, thereby protecting cells from damage and reducing inflammation